| Nathan S Kline Institute |
| Title |
Patent No. |
Pub. Appl |
| Aging, Alzheimer's Disease & Dementia |
| Methods for the Identification of Compounds for the Treatment of Alzheimer’s Disease |
6,838,592 |
|
| Methods for the Identification of Compounds for the Treatment of Neuronal Atrophy-Associated Dementia |
7,090,987 |
|
| Methods for Screening to Identify Therapeutic Agents for Alzheimer's Disease and Use Thereof |
|
20120136064 |
| Methods and Compositions Relating to Cystatin C |
7,790,673 |
WO2005059100 |
| Neuropsychiatric Disorders |
| Treatment of Negative & Cognitive Symptoms of Schizophrenia with D-Serine |
6,162,827 |
|
| Assay for D-Serine Transport Antagonist for Use and for Treating Psychosis |
6,361,957 |
|
| System and Method for Diagnosis & Treatment of Neuropsychiatric Disorders |
8,076,075 |
20120114767 |
| Research Tools |
| Transgenic Mice Comprising a Genomic Human Tau Transgene |
7,161,060 |
|
| Tissue Embedding Matrix |
|
20080009028 |
| Methods and Compositions for Amplification & Detection of microRNAs |
|
20080051296 |
| Various monoclonal antibodies |
Covance antibody products |
| Copyrighted Works Relating to Mental Health |
| Recovery from Schizophrenia: An International Perspective- A Report from the WHO Collaborative Project, the International Study of Schizophrenia |
Copyrighted work |
| Toolkit for Modifying Evidence-Based Practices to Increase Cultural Competence |
Copyrighted work |
| |
|
|
| Institute for Basic Research |
| Title |
Patent No. |
Pub. Appl |
|
|
|
| Aging, Alzheimer’s Disease, Neurodegenerative Diseases & Neuropsychiatric Disorders |
| Method for Differentiation of Alzheimer's Disease into Subgroups |
7,256,003 |
20080070263 |
| LMNA Gene and its Involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and Arteriosclerosis |
8,034,557
|
|
| 7,297,492 |
| Neurotrophic Peptides |
|
20110160141 |
| 20100029572 |
| NMDA Receptor Antagonists and Their Use in Inhibiting Abnormal Hyperphosphorylation of Microtubule Associated Protein Tau |
|
20120157537 |
| System and Method for Evaluating Blood-Neural Barrier Permeability |
|
20100273196 |
| Treatment of Central Nervous System Disorders Associated with Psychotic Behavior and Dementia with a Combination of Neuroleptic Drugs and Taurine, or Derivatives Thereof, to Prevent the Development of Tardive Dyskinesia |
5,602,150 |
|
| Research Tools |
| Detection of Novel Carbohydrates Associated with Chronic Alcoholism |
5,958,785 |
|
| 5,747,346 |
| Systems, Devices, and Methods for Monitoring and Analyzing Research Animal Behavior Before, During, and After Brain Electrical Stimulation |
|
20120143280 |
| Rapid Antemorten Detection of Infectious Agents (infectious agents are prion proteins) |
|
20100261195 |
| Various monoclonal & polyclonal antibodies (amyloid- β peptide, tau proteins, cleavage product of α -secretase, ferritin, spectrin, PrP, etc.) |
Covance antibody products
Others available for licensing |
| Transgenic Mice Expressing Cervid, Ovine, and Human Prion Protein Genes |
Available for licensing |
| Expression & Purification of Recombinant Human Tau in Biologically Active Form |
Available for licensing |
| Human Brain tau441 Stably Transfected PC12 Cell Line |
Available for licensing |
| Copyrighted Works Relating to Mental Health |
| Asperger’s Disorder Behavior Inventory |
Copyrighted work |
| PDD Behavior Inventory |
Copyrighted work |
Health Advocacy Program: An Activity-Based Curriculum for Adults with Developmental Disabilities |
Copyrighted work |
| |
|
|
| New York Psychiatric Institute |
| Title |
Patent No. |
Pub. Appl |
| Columbia Suicide Severity Rating Scale (C-SSRS) |
Copyrighted work |
| Genetic Markers of True Low Birth Weight |
|
20090087845 |
| |
|
|
|
| Top of page |
|
|
|
|
|
|
NOTE: Copyrighted works are to be used with permission of the author only.
